Hopp til hovedinnhold

Innsetting og fjerning av spiral

Sist revidert:
Sist revidert av:
  1. Hardeman J, Weiss BD. Intrauterine devices: an update. Am Fam Physician 2014; 89(6): 445-50. pmid:24695563 PubMed  
  2. Heinemann K, Reed S, Moehner S, Minh TD. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception 2015. PMID: 25601350 PubMed  
  3. O'Brien P, Marfleet CC. Frameless versus classical intrauterine device for contraception. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003282 pmid: 15674904 PubMed  
  4. Krashin J, Tang JH, Mody S, Lopez LM. Hormonal and intrauterine methods for contraception for women aged 25 years and younger. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD009805. pmid: 26280888 PubMed  
  5. Winner B, Peipert JF, Zhao Q et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012; 366(21): 1998-2007. pmid:22621627 PubMed  
  6. Diedrich JT, Klein DA, Peipert JF. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216: 364. pmid:28038902 PubMed  
  7. Norsk gynekologisk forening. Veileder i gynekologi (2021). Prevensjon. Siden besøkt mai 2023. www.legeforeningen.no  
  8. Mantha S, Karp R, Raghavan V, et al. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944. PMID: 22872710 PubMed  
  9. Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 2013 Dec;122(6):1205-13. PMID: 24240244 PubMed  
  10. Turok DK, Gero A, Simmons RG et al. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med. 2021 Jan 28;384(4):335-344. PMID: 33503342 PubMed  
  11. Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2015, Issue 4. Art. No.: CD002126. pmid: 25924648 PubMed  
  12. Ørbo A, Vereide AB, Ames M, Pettersen I, Straume B. Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*. BJOG, 2014; 121 (4): 477-86. PMID: 24286192 PubMed  
  13. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: World Health Organization; 2015. PMID: 26447268 PubMed  
  14. Chen BA, Reeves MF, Hayes JL, et al. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2010; 116: 1079-87. PubMed  
  15. Maquire K, Davis A, Rosario Tejeda L, Westhoff C. Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 2012; 86: 214-9. PubMed  
  16. Lopez LM, Bernholc A, Zeng Y, Allen RH, Bartz D, O'Brien PA, Hubacher D. Interventions for pain with intrauterine device insertion. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No.: CD007373. DOI: 10.1002/14651858.CD007373.pub3. DOI  
  17. Grentzer JM, Peipert JF, Zhao Q et al. Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion. Contraception 2015; 92(4): 313-8. pmid:26093189 PubMed  
  18. American College of Obstetricians and Gynecologists. ACOG committee opinion No. 735, May 2018. Adolescents and long-acting reversible Contraception: Implants and Intrauterine Devices. Siden besøkt 26.10.2018. PMID: 29683910 PubMed  
  19. Girum T, Wasie A. Return of fertility after discontinuation of contraception: a systematic review and meta-analysis. Contracept Reprod Med 2018. pmid:30062044 PubMed  
  20. Prine L, Shah M. Long-Acting Reversible Contraception: Difficult Insertions and Removals. Am Fam Physician 2018; 98: 304-9. pmid:30216029 PubMed  
  21. Aoun J1, Dines VA, Stovall DW et al. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 2014; 123(3): 585-92. pmid:24499755 PubMed  
  22. Jatlaoui TC, Whiteman MK, Jeng G et al. Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis. Obstet Gynecol 2018; 132: 895-905. pmid:30204688 PubMed  
  23. Heinemann K, Reed S, Moehner S, Minh TD. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 2015. PMID: 25601352 PubMed  
  24. Reed SD, Zhou X, Ichikawa L, et al. Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study. Lancet 2022; 399: 2103-12. pmid:35658995 PubMed  
  25. Richards EG, Rehmer JM, Falcone T. Perforation During Gynecological Procedures. JAMA. 2023 Mar 3. Epub ahead of print. PMID: 36867414. PubMed  
  26. Valbø A, Rønning EJ, Aaberg M. Aktinomykose som komplikasjon til spiralbruk. Tidsskr Nor Lægeforen 2010; 130(8): 830-2. pmid:20418928 PubMed  
  27. Widnes AF, Myklebust ÅJ. Forlenget bruk av hormonspiral hos premenopausale kvinner (RELIS). Utposten 2016; 45: 46-7. relis.no  
  • Silje Folven Barlindhaug, spesialist i allmennmedisin, redaktør NEL